Literature DB >> 1756140

Preconditioning myocardium with ischemia.

R B Jennings1, C E Murry, K A Reimer.   

Abstract

Preconditioning and stunning are the chief adaptive changes induced in myocardium by a brief episode of reversible ischemia followed by arterial reperfusion. In the dog heart, both coexist for a period of at least 20 minutes of reperfusion, but after 120 minutes of reflow, preconditioning is much diminished, while stunning remains fully developed. Preconditioned, stunned, myocardium differs from control "virgin" myocardium in that adenine nucleotide content is reduced to about 50-70% of control, whereas creatine phosphate (CP) greatly exceeds normal--the so-called CP overshoot. When preconditioned myocardium is subjected to sustained ischemia, ATP utilization and anaerobic glycolysis occur at much slower rates than those observed in virgin myocardium. As a result of the early difference in metabolic rate, a longer period of ischemia is required for the ATP and lactate of the preconditioned tissue to reach the levels associated with irreversible injury. Associated with this change is a delay in myocyte death. The molecular events responsible for slower ischemic metabolism and associated tolerance of preconditioned, stunned tissue to a new ischemic episode are not known. Among the reactions that could cause a reduction in energy metabolism is reduced approximately P expenditure by stunned myocardium attempting to contract during the initial phase of ischemia. However, results from in vivo and in vitro experiments suggest that although stunning may be necessary for preconditioning to develop, it alone is not sufficient to cause preconditioning. Alternatively, metabolic changes may be explained by depressed activity of the mitochondrial ATPase during the episode of sustained ischemia. However, no direct experimental evidence supporting this hypothesis is available up to the present time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756140     DOI: 10.1007/bf00053555

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  23 in total

1.  Development of cell injury in sustained acute ischemia.

Authors:  R B Jennings; C E Murry; C Steenbergen; K A Reimer
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

2.  Repetitive episodes of brief ischaemia (12 min) do not produce a cumulative depletion of high energy phosphate compounds.

Authors:  J L Swain; R L Sabina; J J Hines; J C Greenfield; E W Holmes
Journal:  Cardiovasc Res       Date:  1984-05       Impact factor: 10.787

3.  Effect of hypothermia on changes in high-energy phosphate production and utilization in total ischemia.

Authors:  R N Jones; K A Reimer; M L Hill; R B Jennings
Journal:  J Mol Cell Cardiol       Date:  1982-09       Impact factor: 5.000

Review 4.  Mechanism of myocardial "stunning".

Authors:  R Bolli
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

5.  Myocardial protection is lost before contractile function recovers from ischemic preconditioning.

Authors:  C E Murry; V J Richard; R B Jennings; K A Reimer
Journal:  Am J Physiol       Date:  1991-03

6.  Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure.

Authors:  R B Jennings; J Schaper; M L Hill; C Steenbergen; K A Reimer
Journal:  Circ Res       Date:  1985-02       Impact factor: 17.367

7.  Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs.

Authors:  K A Reimer; M L Hill; R B Jennings
Journal:  J Mol Cell Cardiol       Date:  1981-02       Impact factor: 5.000

8.  Effects of oligomycin and acidosis on rates of ATP depletion in ischemic heart muscle.

Authors:  W Rouslin; J L Erickson; R J Solaro
Journal:  Am J Physiol       Date:  1986-03

9.  Repeated short periods of regional myocardial ischemia: effect on local function and high energy phosphate levels.

Authors:  H M Hoffmeister; M Mauser; W Schaper
Journal:  Basic Res Cardiol       Date:  1986 Jul-Aug       Impact factor: 17.165

10.  Myocardial protection with preconditioning.

Authors:  G C Li; J A Vasquez; K P Gallagher; B R Lucchesi
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

View more
  11 in total

1.  Hypoxic preconditioning in isolated rat hearts: non-involvement of activation of adenosine A1 receptor, Gi protein, and ATP-sensitive K+ channel.

Authors:  K Yabe; Y Nasa; S Takeo
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

Review 2.  Anesthetic cardioprotection: the role of adenosine.

Authors:  Stephanie Bonney; Kelly Hughes; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.

Authors:  Belma Turan; Erkan Tuncay; Guy Vassort
Journal:  J Bioenerg Biomembr       Date:  2012-04       Impact factor: 2.945

4.  X-ray-visible microcapsules containing mesenchymal stem cells improve hind limb perfusion in a rabbit model of peripheral arterial disease.

Authors:  Dorota A Kedziorek; Lawrence V Hofmann; Yingli Fu; Wesley D Gilson; Kenyatta M Cosby; Bernard Kohl; Brad P Barnett; Brian W Simons; Piotr Walczak; Jeff W M Bulte; Kathleen Gabrielson; Dara L Kraitchman
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

5.  Remote limb ischemic conditioning enhances motor learning in healthy humans.

Authors:  Kendra M Cherry-Allen; Jeff M Gidday; Jin-Moo Lee; Tamara Hershey; Catherine E Lang
Journal:  J Neurophysiol       Date:  2015-04-01       Impact factor: 2.714

6.  Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs.

Authors:  J Z Sun; X L Tang; A A Knowlton; S W Park; Y Qiu; R Bolli
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

7.  Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs.

Authors:  J Z Sun; X L Tang; S W Park; Y Qiu; J F Turrens; R Bolli
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

8.  Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion.

Authors:  Christelle Kamga Pride; Li Mo; Kelly Quesnelle; Ruben K Dagda; Daniel Murillo; Lisa Geary; Catherine Corey; Rafael Portella; Sergey Zharikov; Claudette St Croix; Salony Maniar; Charleen T Chu; Nicholas K H Khoo; Sruti Shiva
Journal:  Cardiovasc Res       Date:  2013-09-30       Impact factor: 10.787

9.  Potential Benefits of Peroxynitrite.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Open Pharmacol J       Date:  2008

10.  TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons.

Authors:  Yasunori Shintani; Amar Kapoor; Masahiro Kaneko; Ryszard T Smolenski; Fulvio D'Acquisto; Steven R Coppen; Narumi Harada-Shoji; Hack Jae Lee; Christoph Thiemermann; Seiji Takashima; Kenta Yashiro; Ken Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.